ARCHIVES

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

This article is from The Cancer Letter archive.

Vol. 24 No. 06 | February 13, 1998

Download PDF Visit The Full Archive

Related Articles

Consructio Needs Over Next Five Years Total Estimated $696 Million; NCI Share-$132 Million

January 19, 1979

ODAC Member Critical Of Amgen For Price Incentives.

March 21, 2008

NIH Programs: Mouse Is next In Line For DNA Sequencing

October 29, 1999

CAP Issues Active Surveillance Guidance For Prostate Cancer

September 5, 2014

Wall Street Analyst Who Sounded Alarm Over Prostate Cancer Drug Provenge In JNCI Settles With SEC Over Shorting Dendreon Stock

December 17, 2013

Cancer Registry Says Paper By Jon Sudbo Was Based On Fabricated Data.

January 27, 2006